A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 02 May 2011 |
| Author/s |
author: Maura Rossi Francesco Scopinaro Enrico Derenzini Lisa Argnani Pier Luigi Zinzani |
| Publication date | May 2, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |